Royce & Associates’s Biolase BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-13
Closed -$336K – 1253
2015
Q1
$336K Buy
+13
New +$368K ﹤0.01% 1105

Other funds holding BIOL

Royce & Associates's BIOL Position: Q2 2015 in Review

Royce & Associates sold out of Biolase (BIOL) in Q2 2015, closing a stake of 13 shares — an estimated $336K sold.

Royce & Associates first reported a position in BIOL in Q1 2015 and held it in 1 quarter. The position peaked at $336K in Q1 2015. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2015.

  • Royce & Associates reported no remaining Biolase position as of Q2 2015 after selling out during the quarter.
  • Royce & Associates sold 13 Biolase shares in Q2 2015, an estimated $336K.
  • Royce & Associates first reported a position in Biolase in Q1 2015 and held it in 1 quarter.
  • Royce & Associates's Biolase position peaked at $336K in Q1 2015.
  • 34 funds tracked by Wall St. Rank held Biolase as of Q2 2015.

Based on Royce & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.